Ventolin Indications/Uses

Nebules: Routine management of chronic bronchospasm - unresponsive to conventional therapy. Treatment of acute severe asthma (status asthmaticus).
Accuhaler: VENTOLIN ACCUHALER can be used in the management of asthma, bronchospasm and/or reversible airways obstruction.
Salbutamol provides short-acting (4-hour) bronchodilation with fast onset (within 5 minutes) in reversible airways obstruction due to asthma. With its fast onset of action, it is particularly suitable for the management and prevention of attack in mild asthma and for the treatment of acute exacerbations in moderate and severe asthma.
VENTOLIN ACCUHALER is particularly suitable for the relief of asthma symptoms. It should be used to relieve symptoms when they occur, and to prevent them in those circumstances recognised by the patient to precipitate an asthma attack (e.g. before exercise or unavoidable allergen exposure).
VENTOLIN ACCUHALER is particularly valuable as relief medication in mild, moderate or severe asthma, provided that reliance on it does not delay the introduction and use of regular inhaled corticosteroid therapy.
Inhaler: VENTOLIN Inhaler provides short-acting (4 to 6 hour) bronchodilatation with fast onset (within 5 minutes) in reversible airways obstruction.
It is particularly suitable for the relief and prevention of asthma symptoms. It should be used to relieve symptoms when they occur, and to prevent them in those circumstances recognised by the patient to precipitate an asthma attack (e.g. before exercise or unavoidable allergen exposure).
VENTOLIN Inhaler is particularly valuable as a relief medication in mild, moderate or severe asthma, provided that reliance on it does not delay the introduction and use of regular inhaled corticosteroid therapy.
Solution for Intravenous Infusion: Salbutamol is a beta-adrenergic stimulant that has a selective action on the beta-2 adrenoceptors in the bronchi and uterus and much less action on the beta-1 adrenoceptors in the heart. VENTOLIN parenteral preparations are indicated for two distinct clinical situations: For the relief of severe bronchospasm associated with asthma or bronchitis and for the treatment of status asthmaticus.
For the short term management of uncomplicated premature labour; to arrest labour between 22 and 37 weeks of gestation in patients with no medical or obstetric contraindication to tocolytic therapy.